Terms: = Pancreatic cancer AND KDM5A, RBBP2, 5927, JARID1A, ENSG00000073614
9 results:
1. KDM5 family of demethylases promotes CD44-mediated chemoresistance in pancreatic adenocarcinomas.
Wang D; Zhang Y; Liao Z; Ge H; Güngör C; Li Y
Sci Rep; 2023 Oct; 13(1):18250. PubMed ID: 37880235
[TBL] [Abstract] [Full Text] [Related]
2. A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma.
Heumann T; Judkins C; Li K; Lim SJ; Hoare J; Parkinson R; Cao H; Zhang T; Gai J; Celiker B; Zhu Q; McPhaul T; Durham J; Purtell K; Klein R; Laheru D; De Jesus-Acosta A; Le DT; Narang A; Anders R; Burkhart R; Burns W; Soares K; Wolfgang C; Thompson E; Jaffee E; Wang H; He J; Zheng L
Nat Commun; 2023 Jun; 14(1):3650. PubMed ID: 37339979
[TBL] [Abstract] [Full Text] [Related]
3. The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms.
Venizelos A; Elvebakken H; Perren A; Nikolaienko O; Deng W; Lothe IMB; Couvelard A; Hjortland GO; Sundlöv A; Svensson J; Garresori H; Kersten C; Hofsli E; Detlefsen S; Krogh M; Sorbye H; Knappskog S
Endocr Relat Cancer; 2021 Nov; 29(1):1-14. PubMed ID: 34647903
[TBL] [Abstract] [Full Text] [Related]
4. Hypoxia promotes the metastasis of pancreatic cancer through regulating NOX4/kdm5a-mediated histone methylation modification changes in a HIF1A-independent manner.
Li H; Peng C; Zhu C; Nie S; Qian X; Shi Z; Shi M; Liang Y; Ding X; Zhang S; Zhang B; Li X; Xu G; Lv Y; Wang L; Friess H; Kong B; Zou X; Shen S
Clin Epigenetics; 2021 Jan; 13(1):18. PubMed ID: 33499904
[TBL] [Abstract] [Full Text] [Related]
5. A novel kdm5a/MPC-1 signaling pathway promotes pancreatic cancer progression via redirecting mitochondrial pyruvate metabolism.
Cui J; Quan M; Xie D; Gao Y; Guha S; Fallon MB; Chen J; Xie K
Oncogene; 2020 Jan; 39(5):1140-1151. PubMed ID: 31641207
[TBL] [Abstract] [Full Text] [Related]
6. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
7. Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine.
Katoh M
Expert Rev Proteomics; 2015 Jun; 12(3):317-28. PubMed ID: 25835095
[TBL] [Abstract] [Full Text] [Related]
8. Dynamic epigenetic regulation by menin during pancreatic islet tumor formation.
Lin W; Watanabe H; Peng S; Francis JM; Kaplan N; Pedamallu CS; Ramachandran A; Agoston A; Bass AJ; Meyerson M
Mol Cancer Res; 2015 Apr; 13(4):689-98. PubMed ID: 25537453
[TBL] [Abstract] [Full Text] [Related]
9. KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.
Tzatsos A; Paskaleva P; Ferrari F; Deshpande V; Stoykova S; Contino G; Wong KK; Lan F; Trojer P; Park PJ; Bardeesy N
J Clin Invest; 2013 Feb; 123(2):727-39. PubMed ID: 23321669
[TBL] [Abstract] [Full Text] [Related]